China Medical System (CMS) stock surged 5% in intraday trading, following the release of its impressive financial results for the first half of 2025. The company reported growth in both revenue and profit, beating analyst estimates and showcasing the success of its strategic transformation.

According to the company's Hong Kong bourse filing, CMS posted a profit attributable to shareholders of 941.2 million yuan for the six months ended June 30, up from 910.4 million yuan in the same period last year. Revenue for the period rose 10.8% to 4 billion yuan, surpassing analysts' forecast of 3.94 billion yuan. Earnings per share increased to 0.3892 yuan, exceeding the Visible Alpha analysts' estimate of 0.35 yuan.

In light of the strong performance, the board declared an interim dividend of 0.1555 yuan per share, up from 0.1507 yuan last year. The company's positive results and increased dividend likely contributed to investor enthusiasm, driving the stock's significant intraday gain. Additionally, CMS announced the resignation of non-executive director Chen Hongbing, who stepped down to focus on personal commitments and family.